Back to Rankings

EPRX

EupraxiaB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
EPRX vs peer average
56/100
EPRX vs. peer average (B vs. B)
Grade spread
A 5 · B 1 · C 1 · D 1 · F 2
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

ARWR is the first available peer comparator.

Small-cap biotech with pipeline-stage risk; useful comparison for binary-outcome repricing behavior.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerARWRArrowhead
EPRX
Eupraxia
ARWR
Arrowhead
Grade
B
A
Momentum
34
86
Value
41
57
Sentiment
100
63
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Constructive

Grade position vs ARWR

EPRX / ARWR
Grade Position
In line
EPRX vs. peer average (B vs. B)
56/100
Momentum
34
ARWR
Value
41
ARWR
Sentiment
100
EPRX

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs EPRX
1
ARWR
ARWR
A
100/100
-1
2
AGEN
AGEN
F
20/100
+3
3
SGMT
Sagimet Biosciences Inc Class A Common
A
100/100
-1
4
NGNE
Neurogene Inc Common
B
80/100
Even
5
CATX
Perspective Therapeutics Inc Common
D
40/100
+2
ARWR is the first peer returned for this comparison set.